Daniel Hoyer

ORCID iD
https://orcid.org/0000-0002-1405-7089
  • Country
  • Show details Hide details
Australia

Sources:
Daniel Hoyer (2016-01-24)

  • Keywords
  • Show details Hide details

Sources:
Daniel Hoyer (2015-04-01)

  • Other IDs
  • Show details Hide details
Scopus Author ID: 7102283515

Sources:
Scopus to ORCID (2015-04-01)

Biography

Publications: >325, citations (google scholar): >25,000, H factor: 79, invited international presentations: >170, 5 patents 30 years of drug discovery / development experience in pharmaceutical industry and Academia Sandoz: 1979–1981; 1983-1997; Novartis: 1997–Nov 2012. Scripps: 2004- present, The University of Melbourne: December 2012 -> present Management of pharmacology research groups, drug discovery programmes, compound profiling teams, translational biology. Responsibility for extensive cross disciplinary internal & external interactions / collaborations. Leadership of large learned societies and numerous editorial and academic activities. Therapeutic / other areas of interest: Sleep disorders, epilepsy, migraine, schizophrenia, anxiety / depression, bipolar disorders, panic, PTSD, Parkinson’s disease / other neurological disorders (MS/ALS/HD/fragile X), irritable bowel syndrome, acromegaly, gastroenteropancreatic and other tumors, hypertension, pulmonary hypertension. PET and other imaging approaches / radiotherapy / electrophysiology / sleep EEG, gene expression profiling, proteomics, SiRNA, epigenetics of mental retardation & Autism Spectrum Disorders. Molecular targets characterised: Monoamine receptors and transporters: 5-HT receptors (all except 5-HT5 and 5-HT6), adrenoceptors (alpha1,2 and beta1,2), dopamine (D2, D3 and D4), 5-HTT, NET, DAT. Peptide and other receptors: Orexin, somatostatin (sst1-sst5), endothelin, CRF, NPS, NPY1,2, neurokinin NK1, sphingolipid S1P1-5, Glutamate (mGluR5, 7), GABAB. Ligand-gated channels and other receptors: 5-HT3, Glutamate (AMPA, Kainate, NMDA), Nicotinic (alpha4beta2, alpha7), GABAA and peripheral benzodiazepine receptors, FMR1 and FMRP.
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
    Created:
No education added yet
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
    Created:
No employment added yet
No publications added yet